Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;20(7):4999-5008.
doi: 10.1002/alz.13826. Epub 2024 Jun 17.

Cerebral amyloid angiopathy and the immune system

Affiliations
Review

Cerebral amyloid angiopathy and the immune system

Danielle Munsterman et al. Alzheimers Dement. 2024 Jul.

Abstract

Cerebral amyloid angiopathy (CAA) is characterized by the accumulation of amyloid protein in the walls of cerebral blood vessels. This deposition of amyloid causes damage to the cerebral vasculature, resulting in blood-brain barrier disruption, cerebral hemorrhage, cognitive decline, and dementia. The role of the immune system in CAA is complex and not fully understood. While the immune system has a clear role in the rare inflammatory variants of CAA (CAA related inflammation and Abeta related angiitis), the more common variants of CAA also have immune system involvement. In a protective role, immune cells may facilitate the clearance of beta-amyloid from the cerebral vasculature. The immune system can also contribute to CAA pathology, promoting vascular injury, blood-brain barrier breakdown, inflammation, and progression of CAA. In this review, we summarize the role of the immune system in CAA, including the potential of immune based treatment strategies to slow vascular disease in CAA and associated cognitive impairment, white matter disease progression, and reduce the risk of cerebral hemorrhage. HIGHLIGHTS: The immune system has a role in cerebral amyloid angiopathy (CAA) which is summarized in this review. There is an inflammatory response to beta-amyloid that may contribute to brain injury and cognitive impairment. Immune cells may facilitate the clearance of beta-amyloid from the cerebral vasculature. Improved understanding of the immune system in CAA may afford novel treatment to improve outcomes in patients with CAA.

Keywords: Abeta related angiitis; CAA related inflammation; cerebral amyloid angiopathy; hemorrhagic stroke; immune response; microbleeds.

PubMed Disclaimer

Conflict of interest statement

Dr Eric E. Smith reports consulting for Eli Lilly and Alnylam and is a site investigator for a clinical trial sponsored by Biogen. All other authors declare no conflicts of interest. Author disclosures are available in the Supporting Information.

References

    1. Greenberg SM, Bacskai BJ, Hernandez‐Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease—one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30‐42. doi:10.1038/s41582-019-0281-2 - DOI - PMC - PubMed
    1. Charidimou A, Boulouis G, Gurol ME, et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140(7):1829‐1850. doi:10.1093/brain/awx047 - DOI - PMC - PubMed
    1. Esiri M, Matthews F, Brayne C, et al. Pathological correlates of late‐onset dementia in a multicentre, community‐based population in England and Wales. Neuropathology group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet. 2001;357(9251):169‐175. - PubMed
    1. Thal DR, Griffin WST, de Vos RA, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol. 2008;115(6):599‐609. - PubMed
    1. Revesz T, Holton JL, Lashley T, et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol. 2009;118(1):115‐130. doi:10.1007/s00401-009-0501-8 - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources